Structures by: Durant F.
Total: 35
C21H20Cl2FNO
C21H20Cl2FNO
Journal of the Chemical Society, Perkin Transactions 2 (2000) 9 1781
a=13.806(3)Å b=14.761(3)Å c=9.6180(19)Å
α=90.00° β=92.77(3)° γ=90.00°
C36H52Cl2CuN4O20
C36H52Cl2CuN4O20
Journal of the Chemical Society, Perkin Transactions 2 (1999) 4 795
a=10.9740(10)Å b=11.4210(10)Å c=11.6980(10)Å
α=114.180(4)° β=93.573(5)° γ=116.809(6)°
C36H32Cl2CuN4O12
C36H32Cl2CuN4O12
Journal of the Chemical Society, Perkin Transactions 2 (1999) 4 795
a=8.5440(10)Å b=8.8580(10)Å c=13.7070(10)Å
α=88.050(5)° β=72.984(5)° γ=64.944(4)°
C57H104O6
C57H104O6
Acta Crystallographica Section B (2000) 56, 2 317-321
a=11.6650(12)Å b=44.933(5)Å c=5.432(6)Å
α=87.034(10)° β=100.17(9)° γ=89.09(9)°
8,8'-dichloro-1,1',5,5'-tetrahydro-10,10'-bipyrrolo[1,2-b] isoquinolin-3,3'(2H,2'H)-dione
C24H18Cl2N2O2
Acta Crystallographica Section E (2003) 59, 7 o1002-o1003
a=8.1130(10)Å b=12.0890(10)Å c=20.181(2)Å
α=90.00° β=92.79(3)° γ=90.00°
Ethyl 2-cyclopentoxy-4-hydroxy-5-ethyl-6-methylnicotinate
C16H23NO4
Acta Crystallographica Section E (2002) 58, 8 o964-o965
a=6.3120(10)Å b=10.5710(10)Å c=12.396(2)Å
α=84.205(7)° β=77.098(8)° γ=88.827(5)°
N-methyl-N-(4-nitro-2-phenoxyphenyl)methanesulfonamide
C14H14N2O5S
Acta Crystallographica Section E (2001) 57, 11 o1012-o1013
a=14.5220(10)Å b=10.4390(10)Å c=10.5230(10)Å
α=90.00° β=109.460(4)° γ=90.00°
N-{[2-carboxy-5-oxopyrrolidin-1-yl](p-tolyl)methyl}pyroglutamic acid
C18H20N2O6
Acta Crystallographica Section E (2001) 57, 5 o439-o440
a=9.0770(10)Å b=11.0650(10)Å c=17.1060(10)Å
α=90.00° β=90.00° γ=90.00°
C11H13NO4
C11H13NO4
Acta Crystallographica Section C (1994) 50, 1 97-100
a=11.546(6)Å b=9.360(2)Å c=4.922(3)Å
α=90.0° β=101.5(2)° γ=90.0°
C12H15NO4
C12H15NO4
Acta Crystallographica Section C (1994) 50, 1 97-100
a=7.295(3)Å b=25.653(5)Å c=6.321(2)Å
α=90.° β=90.° γ=90.°
Oxazolidinone
C3H5NO2
Acta Crystallographica Section C (1997) 53, 7 895-897
a=7.3180(15)Å b=5.6730(11)Å c=9.989(2)Å
α=90.00° β=110.79(3)° γ=90.00°
(5,2'-dithien-2-yl)-2'-deoxyuridine
C17H16N2O5S2
Acta Crystallographica Section C (1997) 53, 7 892-895
a=14.580(2)Å b=18.5345(10)Å c=6.44770(10)Å
α=90.00° β=90.00° γ=90.00°
Lumiflavine
C13H14N6O8
Acta Crystallographica Section C (1995) 51, 6 1223-1227
a=14.0100(10)Å b=7.1040(10)Å c=34.086(2)Å
α=90° β=90° γ=90°
2:1 complex (N-cyclopentyl-4-phenylpyridinium bromide : 4-phenylpyridine)
2C16H18N1,2Br1,C11H9N1,H1Br1,H2O1
Acta Crystallographica Section C (1996) 52, 4 1033-1036
a=14.692(2)Å b=13.8800(10)Å c=9.7590(10)Å
α=90.00° β=90.00° γ=90.00°
3-methyl-1-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole
C17H16N2O2S
Acta Crystallographica Section C (2004) 60, 9 o648-o652
a=11.0070(10)Å b=13.0610(10)Å c=24.2980(10)Å
α=90.00° β=112.652(5)° γ=90.00°
Ethyl 1-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole-3-carboxylate
C19H18N2O4S
Acta Crystallographica Section C (2004) 60, 9 o648-o652
a=19.4790(10)Å b=5.6100(10)Å c=33.586(3)Å
α=90.00° β=90.00° γ=90.00°
2-methyl-6-(4,4,4-trifluorobutoxy)-9H-indeno[1,2-c]pyridazin-9-one
C16H13F3N2O2
Acta Crystallographica Section C (2004) 60, 9 o623-o626
a=4.918(2)Å b=11.978(6)Å c=24.659(5)Å
α=90.00° β=96.65(2)° γ=90.00°
6-methoxy-2-[3-(trifluoromethyl)phenyl]-9H-indeno[1,2-c]pyridazin-9-one
C19H11F3N2O2
Acta Crystallographica Section C (2004) 60, 9 o623-o626
a=10.3060(10)Å b=10.7980(10)Å c=14.9860(10)Å
α=73.453(6)° β=79.592(7)° γ=89.422(7)°
1-[4-(methylsulfonyl)phenyl]-3-[3-(morpholino)phenoxymethyl]-5-phenyl-1H- pyrazole
C27H27N3O4S
Acta Crystallographica Section C (2004) 60, 9 o648-o652
a=10.325(2)Å b=13.874(2)Å c=18.094(2)Å
α=100.823(9)° β=104.704(8)° γ=91.888(11)°
7-methoxy-2-[3-(trifluoromethyl)phenyl]-9H-indeno[1,2-c]pyridazin-9-one
C19H11F3N2O2
Acta Crystallographica Section C (2004) 60, 9 o623-o626
a=7.768(2)Å b=8.750(2)Å c=12.703(2)Å
α=89.010(10)° β=81.59(2)° γ=68.050(10)°
CAROXAZONE
C10H10N2O3
Acta Crystallographica Section C (1994) 50, 11 1774-1777
a=8.0934(10)Å b=19.998(3)Å c=11.926(2)Å
α=90.00° β=90.00° γ=90.00°
P-chlorophenylamidopentanoic acid
C12H14ClNO3
Acta Crystallographica Section C (1994) 50, 1774-1777
a=4.863(5)Å b=9.963(3)Å c=14.024(3)Å
α=69.99(2)° β=76.70(4)° γ=80.28(4)°
C12H15NO2S
C12H15NO2S
Acta Crystallographica Section C (1994) 50, 11 1749-1753
a=12.307(2)Å b=8.305Å c=12.516(2)Å
α=90.0° β=108.29(5)° γ=90.0°
N-(3-phenoxy-4-pyridyl)methanesulfonamide
C12H12N2O3S
Acta Crystallographica Section C (2002) 58, 2 o88-o89
a=8.0590(10)Å b=12.1160(10)Å c=24.744(2)Å
α=90° β=90° γ=90°
N-tert-Butyl-N'-[(2-cyclohexylamino-5-nitrobenzene)sulfonyl]urea
C17H26N4O5S
Acta Crystallographica Section C (2002) 58, 10 o621-o623
a=14.447(5)Å b=11.579(5)Å c=24.981(5)Å
α=90° β=95.195(5)° γ=90°
2-{4-[(3-butyl-1,4-dioxo-2,3-diazaspiro[4.4]non-2-yl)methyl]benzamido}benzoic acid
C26H29N3O5
Acta Crystallographica Section C (2001) 57, 11 1330-1332
a=16.1220(10)Å b=12.6820(10)Å c=11.9200(10)Å
α=90° β=97.139(7)° γ=90°
2-{4-[(3-butyl-1,4-dioxo-2,3-diazaspiro[4.4]non-2-yl)methyl]benzoyl}benzoic acid
C26H28N2O5
Acta Crystallographica Section C (2001) 57, 11 1330-1332
a=10.5300(10)Å b=11.4690(10)Å c=11.4910(10)Å
α=109.589(8)° β=112.690(8)° γ=97.640(9)°
2-{4-[(3-butyl-1,4-dioxo-2,3-diazaspiro[4.4]non-2-yl)methyl]amilinocarbonyl} benzoic acid monohydrate
C26H29N3O5,H2O
Acta Crystallographica Section C (2001) 57, 11 1330-1332
a=18.6810(10)Å b=9.5650(10)Å c=14.8370(10)Å
α=90° β=111.904(7)° γ=90°
Lumiflavine
C13H14N6O8
Acta Crystallographica Section C Crystal Structure Communications (1995) 51, 6 1223
a=14.0100(10)Å b=7.1040(10)Å c=34.086(2)Å
α=90° β=90° γ=90°
3-{4-[3(R)-hydroxybutoxy]phenyl}-(R)-5-methoxymethyloxazolidin-2-one
C15H21NO5
Acta Crystallographica Section C (1994) 50, 9 1490-1492
a=9.387(2)Å b=31.005(8)Å c=5.1952(10)Å
α=90° β=90° γ=90°
Terbogrel
C23H27N5O2
Acta Crystallographica Section C (2000) 56, 10 1265-1266
a=14.9340(10)Å b=10.1150(10)Å c=15.7400(10)Å
α=90.00° β=113.049(5)° γ=90.00°
5-(3,4,5-trimethoxyphenyl)-1,2,3,5,12,12a-hexahydronaphto[1,2-f] indolizine-3,12-dione
C25H23NO5
Acta Crystallographica Section C (2000) 56, 2 193-196
a=10.8680(10)Å b=12.9370(10)Å c=15.0490(10)Å
α=90.00° β=96.009(4)° γ=90.00°
Methyl N-[4-methoxyphenyl-(3,4,5-trimethoxyphenyl)-methyl]pyroglutamate
C23H27NO7
Acta Crystallographica Section C (2000) 56, 2 193-196
a=8.4810(10)Å b=14.2060(10)Å c=18.2730(10)Å
α=90.00° β=90.538(4)° γ=90.00°
5-(3,4,5-trimethoxyphenyl)-1,2,3,5-tetrahydro-11a-naphto[1,8-f,g] indolizine-3-one
C24H23NO4
Acta Crystallographica Section C (2000) 56, 2 193-196
a=9.9090(10)Å b=8.5190(10)Å c=23.7930(10)Å
α=90.00° β=98.104(4)° γ=90.00°
Methyl N-[naphtyl-(3,4,5-trimethoxyphenyl)-methyl]pyroglutamate
C28H30NO8
Acta Crystallographica Section C (2000) 56, 2 193-196
a=9.1900(10)Å b=11.3330(10)Å c=14.7560(10)Å
α=89.292(7)° β=73.923(5)° γ=66.722(7)°